Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Veterinary Dermatology Drugs Market: By Product Type, By Animal Type, By End-user, and Region Forecast 2019-2030
Veterinary Dermatology Drugs Market: By Product Type, By Animal Type, By End-user, and Region Forecast 2019-2030
Veterinary Dermatology Drugs Market size was valued at US$ 3,465.7 million in 2023 and is poised to grow at a CAGR of 6.2% from 2024-2030. The global market is projected to expand at a robust growth rate over the forecast period. The veterinary profession has experienced a dramatic shift over the past few decades. Several demographic and socioeconomic factors have contributed to drastic changes, including livestock, food production, social attitudes, urbanization, and increased adoption of companion animals are expected to fuel the market over the forecast period. Atopic dermatitis is the common cause of itching in companion animals. Atopy is a genetically determined predisposition to become allergic to airborne pollens such as weeds, grass, trees, house dust, and molds. In companion animals dogs, cats atopic dermatitis is the most common cause of chewing, biting, and rubbing as well as chronic skin and ear infections. The surge in the prevalence of chronic skin disorders is anticipated to boost the market revenue size. Increasing demand for the farm animal and poultry sector is expected to boost the market.
Rising awareness regarding various dermatological disorders and treatment methods, and favorable government initiatives in order to increase farm animal production are expected to create demand for the market in the future. Animals are susceptible to numerous chronic skin disorders. Some skin tumors can be treated using medical therapy or cryotherapy. Skin disorders can occur due to various agents such as allergens, burns, external irritants, and trauma (Viral, bacterial, fungal, other parasitic). The evolution of chronic skin diseases and increased mergers & acquisitions to offer better products are able to offer novel products to the market. Rising awareness among pet lovers and increased health checkups are expected to create lucrative opportunities in the future.
Study Period
2024-2030Base Year
2023CAGR
6.2%Largest Market
Middle EastFastest Growing Market
Middle East
Increasing demand for farm animal and poultry sector is expected to boost the veterinary dermatology drugs market. Rising awareness regarding various dermatological disorders and treatment methods, favorable government initiatives in order to increase farm animal production are expected to create demand for market in future. Rising disposable income coupled with rising veterinary healthcare infrastructure are expected to accelerate the Indian market size.
U.S. veterinary dermatology drugs market is expected to dominate revenue share over the forecast period due to increased pet ownership and availability of adequate veterinary healthcare infrastructure have a profound positive impact on the market. For instance, 62% of US households are having a companion animal, equating to 72.9 million homes. Germany's market is anticipated to grow at a modest growth rate over the forecast period, increased awareness is creating demand for the market. Emerging nations China, India, Brazil, Mexico, and Russia are witnessing higher rates of pet adoption due to demographics changes, rising disposable income are few factors. China's market is expanding at a significant growth rate, owing to rising companion animal adoption, and spending on veterinary healthcare is majorly driving the market. Middle East countries are majorly driven by increasing pet adoption coupled with rising veterinary spending.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 3,465.7 million |
|
Market CAGR |
6.2% |
|
By Product Type |
|
|
By Animal type |
|
|
By End-user |
|
Download Free Sample Report
The global veterinary dermatology drugs market size was valued at US$ 3,465.7 million in 2023 and is projected to grow at a CAGR of 6.2% from 2024 to 2030.
The market key players are: Zoetis Inc. Elanco Merial Bayer Animal Health Virbac S.A. IDEXX Laboratories Boehringer Ingelheim Vetmedica Ceva Sante Animale Vetoquinol S.A.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Veterinary Dermatology Drugs Market Introduction |
| 2.1.Global Veterinary Dermatology Drugs Market - Taxonomy |
| 2.2.Global Veterinary Dermatology Drugs Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Animal type |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Veterinary Dermatology Drugs Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Veterinary Dermatology Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Veterinary Dermatology Drugs Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Antibiotics |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. NSAIDS |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Veterinary antifungal drugs |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Veterinary Dermatology Drugs Market By Animal type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Food Animal |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Small Animal |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Equine |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Veterinary Dermatology Drugs Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Veterinary hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Veterinary clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Veterinary Dermatology Drugs Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Veterinary Dermatology Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Antibiotics |
| 9.1.2.NSAIDS |
| 9.1.3.Veterinary antifungal drugs |
| 9.1.4.Others |
| 9.2. Animal type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Food Animal |
| 9.2.2.Small Animal |
| 9.2.3.Equine |
| 9.2.4.Others |
| 9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary hospitals |
| 9.3.2.Veterinary clinics |
| 9.3.3.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Veterinary Dermatology Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Antibiotics |
| 10.1.2.NSAIDS |
| 10.1.3.Veterinary antifungal drugs |
| 10.1.4.Others |
| 10.2. Animal type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Food Animal |
| 10.2.2.Small Animal |
| 10.2.3.Equine |
| 10.2.4.Others |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary hospitals |
| 10.3.2.Veterinary clinics |
| 10.3.3.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Veterinary Dermatology Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Antibiotics |
| 11.1.2.NSAIDS |
| 11.1.3.Veterinary antifungal drugs |
| 11.1.4.Others |
| 11.2. Animal type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Food Animal |
| 11.2.2.Small Animal |
| 11.2.3.Equine |
| 11.2.4.Others |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary hospitals |
| 11.3.2.Veterinary clinics |
| 11.3.3.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Veterinary Dermatology Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Antibiotics |
| 12.1.2.NSAIDS |
| 12.1.3.Veterinary antifungal drugs |
| 12.1.4.Others |
| 12.2. Animal type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Food Animal |
| 12.2.2.Small Animal |
| 12.2.3.Equine |
| 12.2.4.Others |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary hospitals |
| 12.3.2.Veterinary clinics |
| 12.3.3.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Veterinary Dermatology Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Antibiotics |
| 13.1.2.NSAIDS |
| 13.1.3.Veterinary antifungal drugs |
| 13.1.4.Others |
| 13.2. Animal type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Food Animal |
| 13.2.2.Small Animal |
| 13.2.3.Equine |
| 13.2.4.Others |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary hospitals |
| 13.3.2.Veterinary clinics |
| 13.3.3.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis Inc. |
| 14.2.2.Elanco |
| 14.2.3.Merial |
| 14.2.4.Bayer Animal Health |
| 14.2.5.Virbac S.A. |
| 14.2.6.IDEXX Laboratories |
| 14.2.7.Boehringer Ingelheim Vetmedica |
| 14.2.8.Ceva Sante Animale |
| 14.2.9.Vetoquinol S.A. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.